EV/EBITDA
0.92
+0.05+5.75%
Fri, 07 Mar 2025 21:00:11 GMT
Summary
- As of March 10, 2025, APRE EV/EBITDA is 0.92, with a rise of +0.05 (+5.75%) during the most recent trading day.
- Over the past year, APRE EV/EBITDA has increased by +1.46 (+270.37%).
- APRE EV/EBITDA is now -17.86% below its all-time high of 1.12.
Performance
APRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APRE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.8% | -6.4% | -6.0% |
| 1 m1 month | +130.0% | -131.5% | -37.9% |
| 3 m3 months | +95.7% | -95.3% | -34.4% |
| 6 m6 months | +24.3% | -29.4% | -30.4% |
| ytdytd | +55.9% | -55.3% | -27.6% |
| 1 y1 year | +270.4% | -263.9% | -70.9% |
| 5 y5 years | +104.3% | -102.1% | -99.7% |
APRE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.1% | 0.40 | +130.0% | |
| 3 m | 3-month | 0.93 | -1.1% | 0.20 | +360.0% |
| 6 m | 6-month | 0.97 | -5.2% | 0.14 | +557.1% |
| 1 y | 1-year | 0.97 | -5.2% | -1.04 | +188.5% |
| 3 y | 3-year | 1.12 | -17.9% | -1.04 | +188.5% |
| 5 y | 5-year | 1.12 | -17.9% | -25.00 | +103.7% |
| alltime | all time | 1.12 | -17.9% | -42.79 | +102.2% |
Aprea Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.92(+55.9%) |
| 2024 | 0.59(+156.5%) |
| 2023 | 0.23(-23.3%) |
| Date | Value |
|---|---|
| 2022 | 0.30(-211.1%) |
| 2021 | -0.27(-10.0%) |
| 2020 | -0.30(-98.9%) |
| 2019 | -28.43 |
FAQ
- What is Aprea Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aprea Therapeutics?
- What is APRE EV/EBITDA year-to-date change?
- What is Aprea Therapeutics EV/EBITDA year-on-year change?
What is Aprea Therapeutics EV/EBITDA?
The current EV/EBITDA of APRE is 0.92
What is the all time high EV/EBITDA for Aprea Therapeutics?
Aprea Therapeutics all-time high EV/EBITDA is 1.12
What is APRE EV/EBITDA year-to-date change?
Aprea Therapeutics EV/EBITDA has changed by +0.33 (+55.93%) since the beginning of the year
What is Aprea Therapeutics EV/EBITDA year-on-year change?
Over the past year, APRE EV/EBITDA has changed by +1.46 (+270.37%)